Document is current
Any future updates will be listed below
-
Authors
Bastiancich, Chiara https://orcid.org/0000-0003-2758-5654
Snacel-Fazy, Emmanuel
Fernandez, Samantha
Robert, Stéphane
Stacchini, Roberta
Plantureux, Léa
Boissonneau, Sébastien
Testud, Benoit
Guillet, Benjamin
Debarbieux, Franck
Luche, Hervé
Figarella-Branger, Dominique
Estève, Marie-Anne
Tabouret, Emeline
Tchoghandjian, Aurélie
-
Funding
Funding for this research was provided by:
Agence Nationale de la Recherche (JCJC MEGA-01)
Fondation ARC pour la Recherche sur le Cancer (PDF20190509176, ARCPJA12020060002222, ARCPJA2023070006751)
Canceropôle Provence-Alpes-Côte d’Azur (Emergence 2021, mobility grant)
Association pour la Recherche sur les Tumeurs Cérébrales (Emergence 2021)
Société Française de Pharmacie Oncologique SFPO (Elie Bzoura 2021)
Académie Nationale de Pharmacie (Elie Bzoura 2021)
Institut Cancer et Immunologie Aix-Marseille Université
- License Information
-
More Information
Article History
Received: 31 July 2024
Accepted: 11 November 2024
First Online: 28 November 2024
Declarations
:
: All patient data were obtained according to a protocol approved by the local institutional review board and ethical committee (PADS 20–343). The present study was conducted in accordance with the declaration of Helsinki. The in vivo experiments reported in this work have been approved by the institution’s Animal Care and Use Committee (CE71, Aix-Marseille Université, reference n° 22185) and performed following the French national regulation guidelines in accordance with EU Directive 2010/63/EU.
: The authors report no competing interests within this study.
